Skinvisible Pharmaceuticals' sanitizer kills most H1N1
This article was originally published in The Tan Sheet
Executive Summary
The Las Vegas-based firm says its hand sanitizer lotion DermSafe kills/inactivates the H1N1 virus to the same detection level as 70 percent alcohol, as demonstrated in clinical tests by Bioscience Laboratories. Skinvisible says the outcome confirms an in-vitro study conducted at the European contract research organization Retroscreen Virology, which found the product kills/inactivates 99.9 percent of H1N1. The firm adds the study "proves that Dermsafe is an effective alternative to alcohol, without the drying and safety issues." The sanitizer uses the firm's Invisicare polymer delivery system that binds to skin, resisting wash-off for up to four hours. FDA and the Federal Trade Commission have joined forces to crack down on marketing unapproved products making H1N1 claims (1"The Tan Sheet" Oct. 19, 2009)
You may also be interested in...
FTC Stakes New Territory, Joins FDA In Warning On H1N1 Claims
A warning letter sent jointly by FDA and the Federal Trade Commission takes a double-pronged approach toward cracking down on a supplement marketer's claims regarding the H1N1 flu virus
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.